The Efficacy of Stinging Nettle (Urtica Dioica) in Patients with Benign Prostatic Hyperplasia: A Randomized Double-Blind Study in 100 Patients

The Efficacy of Stinging Nettle (Urtica Dioica) in Patients with Benign Prostatic Hyperplasia

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201107295069N4

Enrollment

100

Registered

2011-08-03

Start date

2011-05-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia. ????? ??? ??? ??? ???????

Interventions

Intervention 1: Stinging Nettle, 300 mg capsule twice a day for 8 weeks in intervention group. Intervention 2: Placebo, 300 mg capsule twice a day for 8 weeks in control group.

Treatment - Drugs

Stinging Nettle, 300 mg capsule twice a day for 8 weeks in intervention group

Placebo, 300 mg capsule twice a day for 8 weeks in control group

Eligibility

Sex/Gender

Male

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: known case of Benign Prostatic Hyperplasia, between 40 and 80 years old. Exclusion criteria: the presence of urinary and kidney diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Stinging Nettle Medicine. Timepoint: before intervention and every week for eight weeks. Method of measurement: Prostate Symptom Severity Measuring Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaman Moosavian

Gachsaran Islamic Azad University

info@iaug.ac.ir+98 74 2333 4607

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026